Reducing addiction, promoting competition FDA priorities for 2018
The Food and Drug Administration today announced four priority areas for additional policy activity in 2018: reducing addiction to opioid drugs and cigarettes; promoting innovation and competition; empowering consumers to make informed decisions; and strengthening the FDA workforce. Specific policy efforts include new steps to support and streamline development and approval of treatments that address addiction; reducing burdens for creating and approving generic drugs; and extending new hiring and pay authorities to recruit and retain FDA staff.
Related News Articles
Headline
AdventHealth’s Be a Mindleader initiative aims to help children and parents become more comfortable discussing mental health and connect families to counseling…
Headline
Access to quality mental and physical health services can be a complex challenge, but for individuals of color and people with severe or chronic mental…
Blog
EnglISH¿Qué pasa si una conversación puede cambiar, o incluso salvar, una vida? Esa fue la pregunta que AdventHealth buscó responder, cuando el sistema de…
Blog
ESPAÑOLWhat if one conversation can change, or even save, a life? That was the question AdventHealth sought to answer, as the health system launched a…
Headline
The Substance Abuse and Mental Health Services Administration June 8 announced the availability of $27.5 million in funding opportunities focused on improving…
Headline
AHA June 27 released the first three of a series of videos highlighting various behavioral health roles and career paths in a hospital or health system, as…